Human study · Research · 16 Nov 2026
In an NHANES III cohort, one metabolic fatty-liver pattern lined up with higher mortality than two other patterns
Source: Endocrine
What the research found
A cohort analysis of NHANES III was published online on 16 November 2026. The main contrast used 4,437 people. A sensitivity check used 12,351. The abstract does not give age or sex. Groups were cryptogenic steatotic liver disease, lean metabolic-syndrome-related fatty liver, overweight-only fatty liver (body mass index at least 25 without those metabolic abnormalities), and healthy controls. Median follow-up was 27.4 years. In fully adjusted models, the lean metabolic-syndrome pattern had higher all-cause mortality than cryptogenic disease and than overweight-only disease. Those two groups did not differ clearly from healthy controls. The overweight metabolic-syndrome pattern showed a weaker contrast. The abstract does not give the hazard ratios. When a waist-based index replaced body mass index, overweight-only disease had higher mortality than controls. An association from an older survey, followed for deaths. DOI 10.1007/s12020-026-04814-1. Not medical advice.
Evidence level: Human study. A study in people, but an association isn't proof of cause.
More research news
- In 323 people having rheumatic valve surgery, a biatrial maze cut recurrent atrial fibrillation more than a left-sided maze
- Across 21 studies, people after ACL reconstruction had slower reaction times than people with healthy knees
- In 28 women with early breast cancer, adding fluzoparib to chemotherapy left a low rate of minimal residual tumor
- In 21 post-menopausal women, hormone replacement did not raise nitric-oxide skin blood flow during local heating
- In 12 healthy young adults, 15 minutes of movement or meditation did not beat quiet rest after a fatiguing task